eMed, LLC is a digital health platform founded in 2020 that focuses on employer-sponsored preemptive health management. The company specializes in programs for GLP-1 weight loss, integrating FDA-approved medications such as Wegovy and Ozempic with continuous virtual care, at-home blood testing, and personalized support.
The company operates at the intersection of telehealth, digital health, and at-home diagnostics. Its model is designed to provide clinically guided care through a combination of medication management and ongoing digital support services.
eMed has made notable leadership appointments, including former X CEO Linda Yaccarino and Chief Wellness Officer Tom Brady.
